Agronomics Regulatory News (ANIC)

3rd November 2022

Agronomics Limited

("Agronomics" or the "Company")

Agronomics Capital Markets Day Thursday 3rd November

Agronomics (AIM:ANIC), the leading listed company focused on the field of cellular agriculture, would like to remind everyone that the capital markets webinar will be taking place today, between 2:00 pm - 4:30 pm GMT, to introduce investors, analysts and media to cellular agriculture and a selection of leading companies in the portfolio covering cell culture and precision fermentation technologies.

Agronomics Overview

2:00 - Anthony Chow, Co-founder of Agronomics

2:15 - Question time

Precision Fermentation Highlights - Dairy, Eggs and Contract Manufacturing for Scale-up

2:30 - Jan Pacas, Founder & CEO of All G Foods

2:45 - Mark Warner, Co-founder & CEO of Liberation Labs

3:00 - Maija Itkonen, Co-founder & CEO of Onego Bio

3:15 - Question time

Cultivated Meat and Materials Highlights -Bluefin Tuna, Pork and Leather

3:30 - Lou Cooperhouse, Co-founder & CEO of BlueNalu

3:45 - Krijn de Nood, Co-founder & CEO of Meatable

4:00 - Ingvar Helgason, Co-founder & CEO of VitroLabs

4:15 - Question time

For registration and further details, please use the following link:

https://events.masterinvestor.co.uk/events/agronomics-capital-markets-day/

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 24 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing food security, human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

About Onego Bio Ltd

Onego Bio Ltd is a game-changing biotech company producing animal-free egg proteins with precision fermentation. When implemented in full scale, this new production method provides significant benefits to the environment, food security, as well as animal welfare. The team believes the chosen technology is superior because of its efficiency and productivity. Based on the anticipatory LCA published in Nature Food, the technology shows potential to significantly reduce most agriculture-associated impacts, such as global warming and land use.

Egg is one of the world's most used animal proteins and difficult to replace with alternative ingredients. Onego Bio will make it possible to manufacture the same delicious foods entirely animal-free. Company aims to launch its first product Bioalbumen™ as a food ingredient for food industry and later enter the consumer market with its own branded products for baking and cooking. Bioalbumen provides the nutritional and functional upsides of egg white, without the environmental, ethical and safety-related concerns.

Founded in 2022 by Maija Itkonen (CEO), Christopher Landowski (CTO) and Jussi Joensuu (COO), Onego Bio is a VTT spin-off that salutes the remarkable work done by VTT Technical Research Centre of Finland for the next level cell ag products and applications. Onego Bio's mission is to rethink eggs and give people access to sustainable, delicious and healthy animal-free food. Learn more at www.onego.bio and follow our journey in LinkedIn, Twitter and Instagram.

About All G Foods

All G Foods know that proteins created through animal agriculture can't feed the next generations of humans. The team's mission is to design a sustainable food future - one that is limitlessly good. All G Foods believe the solution to the growing protein demand is innovative, affordable, delicious, nutritious, and sustainable alternative proteins, and are leading technological innovations for the creation of next generation dairy and meat. All G Foods are a trajectory to develop the world's first-to-market identical dairy milk, entirely animal free through precision fermentation and are doing plant-based meat differently to any other brand with their Love BUDS™ products.

About Liberation Labs

Liberation Labs was formed to address the growing fermentation capacity gap in cellular agriculture by providing the industry with the infrastructure to commercialise novel protein manufacturing at the scale and cost structure required by the market. Specifically, Liberation Labs is developing a global network of fit-for-purpose precision fermentation facilities located in the geographies that will drive market access for novel protein companies to commercially succeed, enabling them to achieve price parity with animal proteins. Founded by industry leaders with decades of experience in deployment of precision fermentation facilities and commercial expertise in fermentation market dynamics, our vision is to enable the technology that frees the world from the costs of industrialised agriculture.

About Meatable

Meatable is an innovative, Dutch food company, aiming to deliver, at scale, the new natural, cultivated meat that looks like, tastes like, and has the nutritional profile of traditional meat. Its proprietary opti-ox™ technology enables Meatable to produce meat rapidly, sustainably, and without harming animals. Founded in 2018 by Krijn de Nood (CEO), Daan Luining (CTO), and Dr. Mark Kotter (principal inventor of opti-ox™technology), Meatable has brought together a team of experts with unique knowledge in fields including molecular biology, chemistry, tissue engineering, bioprocess development, food safety, and food science to create the new natural meat.

Follow Meatable: LinkedIn,Twitter, Instagram, Facebook.

About BlueNalu  

BlueNalu's mission is to develop great-tasting, healthy, safe and trusted cell-cultured seafood products that support the sustainability and diversity of our ocean. The company has developed a robust pipeline of seafood products from a wide array of species and plans to launch its first commercial product, premium bluefin tuna toro, following regulatory approval. BlueNalu is a member of the United Nations Global Compact and aligned with the UN Sustainable Development Goals, a blueprint to achieve a better and more resilient future for our planet. BlueNalu began its operations in 2018 and is based in San Diego, California. To learn more about BlueNalu, please visit www.BlueNalu.com

About VitroLabs

VitroLabs, founded in 2016 and headquartered in Milpitas California, is a biotech company developing a scalable tissue engineering platform for the efficient and environmentally friendly production of leather from only a few cells. Combining advanced tissue engineering processes with proprietary advances to achieve commercial scale, VitroLabs is on a mission to produce cell cultivated leather that achieves the look, feel and performance of traditional leather without compromise. The cultivated leather process involves taking a one-time collection of cells from an animal, which then grows in a nutrient-rich environment. Without ever going back to the animal again, the cells grow, divide, and form into tissue. The composition of the material achieves the complexity of traditional hides, containing a variety of proteins that make up a durable and luxurious material when finished, but without the need to go to animals as an ongoing source of hides. The process is more environmentally sustainable and favorable for animal welfare than that which is used to produce traditional leather. For more information, visit www.vitrolabsinc.com.

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5℃

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 4 billion has been invested worldwide since the industry's inception in 2016.

For further information please contact: